Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients Luis Alberto Vigara; Florentino Villanego; Cristhian Orellana; Myriam Eady; María Gabriela Sánchez; Marta Alonso; María Belén García; José Manuel Amaro; Teresa García; Auxiliadora Mazuecos;

Social determinants of health influencing the choice of dialysis modality in advanced chronic kidney disease: Need of an interdisciplinary approach María Dolores Arenas; Marisol Fernández-Chamarro; Guillermo Pedreira-Robles; Silvia Collado; Julia Farrera; Isabel Galceran; Francesc Barbosa; Higini Cao; Alicia Moreno; Laura Morro; Jose Luis Fernández-Martin; Marta Crespo; Julio Pascual;

Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio Anna Vidal-Alabró; Helena Colom; Pere Fontova; Gema Cerezo; Edoardo Melilli; Nuria Montero; Ana Coloma; Anna Manonelles; Alex Favà; Josep M. Cruzado; Joan Torras; Josep M. Grinyó; Nuria Lloberas;